Navigation Links
Biotech firm has strokes, Alzheimer's in its sights

Madison, Wis. - While much of the attention paid to Quincy Bioscience centers on the compound it is developing from jellyfish, it is the company's emerging business model that may put other medical treatments 25,000 leagues under the sea.

Quincy Bioscience is based in Madison's University Research Park, but it derives its research supp......

Full article >>> ept/Psychology/faculty/moyer.html">James Moyer, said lab results thus far indicate the protein, aequorin, is much more "neuroprotective" than existing treatments. According to Underwood, aequorin has helped anywhere from 28 to 45 percent of brain cells survive, without toxicity, after being subjected to the lab equivalent of a stroke.

Ninety-nine percent of the body's calcium is conta......

Full article >>> sing the role future funding will play.

The company expects to have a pharmaceutical product on the market in seven years. It will seek to raise private equity to develop aequorin-based therapies for each disease it targets, starting with strokes and followed (not necessarily in this order) by Alzheimer's, Parkinson's, Huntington's, and Amyotrophic Lateral Sclerosis (ALS), also known as ......

Full article >>> property portfolio.

IQ visions

Quincy's science and the business model may take it farther than most biotechs, but it's the Milwaukee-Madison connection that intrigues Leonhart and others that envision a robust IQ Corridor. "It kind of shows that the research in this state can be created anywhere and be successfully planted elsewhere," he said.

......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 08/31/06


Related biology technology :

1. Biotech officials praise focus of new venture fund
2. Biotech executive books a career flight thats closer to home
3. Gala Biotech among companies sold for $3.3 billion
4. Biotech with Madison ties raises $21M in capital
5. Biotech firm uses live heart tissue in drug screens
6. Biotech talent drew venture-funded firm to Madison
7. 42 days until the 2006 Olympics of Biotechnology in Chicago
8. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
9. Biotech leads list of top U.S. companies to work for
10. Biotech flourishes in 2005 while Big Pharma is on the decline
11. Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/6/2018)... ... November 06, 2018 , ... Crucial Data Solutions announces the ... management. TrialKit ™, an eClinical platform, has incorporated Apple’s biometric technologies for ... sign in to the app via facial recognition or fingerprint recognition. , ...
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD ... by Siemens Healthineers and several healthcare VC firms announces at Distributed Health 2018 ... a history by purchasing tokens and obtaining its first radiology interpretations, one of ...
(Date:11/5/2018)... ... November 05, 2018 , ... 2Blades has completed a ... (TAL) effector code technology for applications in advancing research in epigenetic technology. ... its discovery in 2009, the efficacy of TAL effector-based DNA targeting has been ...
(Date:11/3/2018)... DURHAM, N.C. (PRWEB) , ... November 01, 2018 , ... ... recognized by Inc. Magazine as one of the fastest-growing private companies in the United ... the Inc. 5000 list ranks private companies based on percentage revenue growth over the ...
Breaking Biology Technology:
(Date:11/7/2018)... FRANCISCO (PRWEB) , ... November 07, 2018 , ... ... of Dr. Catherine Lozupone, PhD, faculty of the Computational Biosciences Program within the ... the board of leading scientists and doctors from around the world, Dr. Lozupone ...
(Date:11/7/2018)... SOUTH JORDAN, Utah and BOSTON, Mass. (PRWEB) , ... ... ... global leader in delivering cloud-based enterprise-class unified communications and collaboration solutions, announced today ... and innovative white label exclusive website and a newly established reseller ...
(Date:11/6/2018)... ... November 06, 2018 , ... uBiome, the leader in microbial genomics, today announced ... of California, San Francisco (UCSF) and Co-President of Chan Zuckerberg Biohub, to its Board ... 2013, and we are honored that he is expanding his role as a member ...
Breaking Biology News(10 mins):